Volume 8 Issue 2-3
Oct.  2020
Turn off MathJax
Article Contents
Tian-bin SONG, Jie LU. Diffusion-Weighted Imaging in Neoadjuvant Chemoradiotherapy for Rectal Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(2-3): 100-105. doi: 10.3969/j.issn.1674-9081.2017.03.004
Citation: Tian-bin SONG, Jie LU. Diffusion-Weighted Imaging in Neoadjuvant Chemoradiotherapy for Rectal Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(2-3): 100-105. doi: 10.3969/j.issn.1674-9081.2017.03.004

Diffusion-Weighted Imaging in Neoadjuvant Chemoradiotherapy for Rectal Cancer

doi: 10.3969/j.issn.1674-9081.2017.03.004
More Information
  • Corresponding author: LU Jie  Tel: 010-83198379, Email:imaginglu@hotmail.com
  • Received Date: 2017-05-06
  • Publish Date: 2020-10-30
  • Preoperative neoadjuvant chemoradiotherapy is a routine treatment for rectal cancer. It helps to reduce rectal cancer staging, improve anus preservation rate, reduce local recurrence and achieve complete response. Diffusion-weighted imaging (DWI) provides information of molecular function of tumor. It can be used to evaluate the effect of neoadjuvant chemoradiotherapy treatment for rectal cancer. The value of DWI in preoperative neoadjuvant chemotherapy of patients with rectal cancer including monitoring early stage of therapy effect, tumor remnants, clinical and pathological response, as well as its limitations are focused in this review.

  • loading
  • [1] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2016, 66:115-132. doi:  10.3322/caac.21338
    [2] Govindarajan A, Coburn NG, Kiss A, et al.Population-based assessment of the surgical management of locally advanced colorectal cancer[J].J Natl Cancer Inst, 2006, 98:1474-1481. doi:  10.1093/jnci/djj396
    [3] Wilke H, Preusser P, Fink U, et al.Preoperative chemotherapy in locally advanced and nonresectable gastric cancer:a phase Ⅱ study with etoposide, doxorubicin, and cisplatin[J].J Clin Oncol, 1989, 7:1318-1326. doi:  10.1200/JCO.1989.7.9.1318
    [4] Martellucci J, Scheiterle M, Lorenzi B, et al.Accuracy of transrectal ultrasound after preoperative radiochemotherapy compared to computed tomography and magnetic resonance in locally advanced rectal cancer[J]. Int J Colorectal Dis, 2012, 27:967-973. doi:  10.1007/s00384-012-1419-5
    [5] Marone P, de Bellis M, Avallone A, et al.Accuracy of endoscopic ultrasound in staging and restaging patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation[J].Clin Res Hepatol Gastroenterol, 2011, 35:666-670. doi:  10.1016/j.clinre.2011.05.012
    [6] Lee CT, Chow NH, Liu YS, et al.Computed tomography with histological correlation for evaluating tumor regression of rectal carcinoma after preoperative chemoradiation therapy[J]. Hepatogastroenterology, 2012, 59:2484-2489. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=a4f75c9663c3553db2d34c20de8e6372
    [7] Pomerri F, Pucciarelli S, Maretto I, et al.Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer[J]. Surgery, 2011, 149:56-64. doi:  10.1016/j.surg.2010.03.025
    [8] Kim DJ, Kim JH, Lim JS, et al.Restaging of Rectal Cancer with MR Imaging after Concurrent Chemotherapy and Radiation Therapy[J]. Rdiographics, 2010, 30:503-516. doi:  10.1148/rg.302095046
    [9] Torkzad MR, Lindholm J, Martling A, et al.MRI after preoperative radiotherapy for rectal cancer; correlation with histopathology and the role of volumetry[J].Eur Radiology, 2007, 17:1566-1573. doi:  10.1007/s00330-006-0518-5
    [10] Jia H, Ma X, Zhao Y, et al.Meta-analysis of diffusion-weighted magnetic resonance imaging in identification of colorectal cancer[J].Int J Clin Exp Med, 2015, 8:17333-17342.
    [11] 顾晋, 李明.复发性胃肠道肿瘤的新辅助治疗[J].中国实用外科杂志, 2004, 24:392-394. doi:  10.3321/j.issn:1005-2208.2004.07.005
    [12] Beppu N, Matsubara N, Noda M, et al.Short-course radiotherapy with delayed surgery versus conventional chemoradiotherapy:A comparison of the short-and long-term outcomes in patients with T3 rectal cancer[J].Surgery, 2015, 158:225-235. doi:  10.1016/j.surg.2015.03.014
    [13] 梁晓, 张红梅, 叶枫, 等.扩散加权成像在预测直肠癌术前放化疗疗效中的价值[J].中华肿瘤杂志, 2016, 38:133-137. doi:  10.3760/cma.j.issn.0253-3766.2016.02.011
    [14] Mckeown E, Nelson DW, Johnson EK, et al.Current approaches and challenges for monitoring treatment response in colon and rectal cancer[J].J Cancer, 2014, 5:31-43. doi:  10.7150/jca.7987
    [15] Ferrari L, Fichera A.Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer[J].Gastroenterol Rep(Oxf), 2015, 3:277-288. http://www.ncbi.nlm.nih.gov/pubmed/26290512
    [16] Wagman R, Minsky BD, Cohen AM, et al.Sphincter preservation with preoperative radiation therapy and coloanal anastomosis:Long term follow-up[J].Int J Radiat Oncol Biol Phys, 1998, 42:51-57. doi:  10.1016/S0360-3016(98)00180-1
    [17] Rao SX, Zeng MS, Chen CZ, et al.The value of diffusion-weighted imaging in combination with T2-weighted imaging for rectal cancer detection[J].Eur J Radiol, 2008, 65:299-303. doi:  10.1016/j.ejrad.2007.04.001
    [18] 孙应实, 张晓鹏, 唐磊.直肠癌扩散加权成像b值选取及其对直肠癌显示能力的评价[J].中国医学影像术, 2005, 21:1839-1843. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgyxyxjs200512013
    [19] Sun Y, Tong T, Cai S, et al.Apparent Coefficient (ADC) Value:A Potential Imaging Biomarker That Reflects the Biological Features of Rectal Cancer[J].PLoS One, 2014, 9:e109371.
    [20] 赵海, 高明勇, 谭湘萍, 等.磁共振扩散加权成像预测、监测直肠癌放化疗效果的价值[J].临床放射学杂志, 2011, 6:826-829. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=lcfsxzz201106015
    [21] 曹务腾, 周智洋, 邓艳红, 等.磁共振扩散加权成像对直肠癌新辅助治疗后病理完全缓解的预测价值[J].中华胃肠外科杂志, 2013, 16:1164-1168. doi:  10.3760/cma.j.issn.1671-0274.2013.12.010
    [22] Ha HI, Kim AY, Yu CS, et al. Locally advanced rectal cancer:diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy[J].Eur Radiol, 2013, 23:3345-3353. doi:  10.1007/s00330-013-2936-5
    [23] Song I, Kim SH, Lee SJ, et al.Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer:comparison with T2 weighted and PET/CT imaging[J].Br J Radiol, 2012, 85:577-586. doi:  10.1259/bjr/68424021
    [24] Dresen RC, Beets GL, Rutten HJ, et al. Locally advanced rectal cancer:MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part Ⅰ. Are we able to predict tumor confined to the rectal wall?[J].Radiology, 2009, 252:71-80. doi:  10.1148/radiol.2521081200
    [25] Kim YH, Kim DY, Kim TH, et al. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer[J].Int J Radiat Oncol Biol Phys, 2005, 62:761-768. doi:  10.1016/j.ijrobp.2004.11.005
    [26] Allen SD, Padhani AR, Dzik-Jurasz AS, et al.Rectal carcinoma:MRI with histologic correlation before and after chemoradiation therapy[J].AJR Am J Roentgenol, 2007, 188:442-451. doi:  10.2214/AJR.05.1967
    [27] Patterson DM, Padhani AR, Collins DJ. Technology insight:water diffusion MRI-a potential new biomarker of response to cancer therapy[J].Nat Clin Pract Oncol, 2008, 5:220-233. http://www.ncbi.nlm.nih.gov/pubmed/18301415
    [28] Sun YS, Cui Y, Tang L, et al.Early evaluation of cancer response by a new functional biomarker:apparent diffusion coefficient[J].AJR Am J Roentgenol, 2011, 197:W23-W29. doi:  10.2214/AJR.10.4912
    [29] Kim SH, Lee JM, Hong SH, et al.Locally advanced rectal cancer:added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo-and radiation therapy[J].Radiology, 2009, 253:116-125. doi:  10.1148/radiol.2532090027
    [30] Sun YS, Zhang XP, Tang L, et al.Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy:preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging[J].Radiology, 2010, 254:170-178. doi:  10.1148/radiol.2541082230
    [31] Koh DM, Collins DJ.Diffusion-weighted MRI in the body:applications and challenges in oncology[J].AJR Am J Roentgenol, 2007, 188:1622-1635. doi:  10.2214/AJR.06.1403
    [32] 孙应实, 张晓鹏, 唐磊, 等.表观扩散系数值评价直肠癌术前放化疗疗效的价值[J].中华放射学杂志, 2010, 44:392-396. doi:  10.3760/cma.j.issn.1005-1201.2010.04.015
    [33] Maas M, Nelemans PJ, Valentini V, et al.Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer:a pooled analysis of individual patient data[J].Lancet Oncol, 2010, 11:835-844. doi:  10.1016/S1470-2045(10)70172-8
    [34] Birlik B, Obuz F, Elibol FD, et al.Diffusion-weighted MRI and MR-volumetry-in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer[J]. Magn Reson Imaging, 2015, 33:201-212. doi:  10.1016/j.mri.2014.08.041
    [35] Lambregts DM, Lahaye MJ, Heijnen LA, et al.MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy[J].Eur Radiology, 2016, 26:2118-2125. doi:  10.1007/s00330-015-4062-z
    [36] Lambregts DM, Beets GL, Maas M, et al.Tumour ADC measurements in rectal cancer:effect of ROI methods on ADC values and interobserver variability[J].Eur Radiology, 2011, 21:2567-2574. doi:  10.1007/s00330-011-2220-5
    [37] Lambrecht M, Vandecaveye V, De Keyzer F, et al.Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer:preliminary results[J].Int J Radiat Oncol Biol Phys, 2012, 82:863-870. doi:  10.1016/j.ijrobp.2010.12.063
    [38] Barbaro B, Vitale R, Valentini V, et al. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant Chemoradiotherapy[J]. Int J Radiat Oncol Biol Phys, 2012, 83:594-599. doi:  10.1016/j.ijrobp.2011.07.017
    [39] Haiting Xie, Tao Sun, Ming Chen, et al.Effectiveness of the apparent diffusion coefficient for predicting the response to chemoradiation therapy in locally advanced rectal cancer[J]. Medicine, 2015, 94:e517. doi:  10.1097/MD.0000000000000517
    [40] Nougaret S, Vargas H A, Lakhman Y, et al.Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer:Initial Experience and Comparison between Single-Section and Volumetric Analyses[J].Radiology, 2016, 280:446-454. doi:  10.1148/radiol.2016150702
    [41] Freiman M, Voss SD, Mulkern RV, et al. In vivo assessment of optimal b-value range for perfusion-insensitive apparent diffusion coefficient imaging[J].Med Phys, 2012, 39:4832-4839. doi:  10.1118/1.4736516
    [42] Freiman M, Voss SD, Mulkern RV, et al. Reliable assessment of perfusivity and diffusivity from diffusion imaging of the body[J].Med Image Comput Comput Assist Interv, 2012, 15:1-9. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=CC0213285698
  • 加载中


    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (210) PDF downloads(7) Cited by()
    Proportional views


    DownLoad:  Full-Size Img  PowerPoint